The telemedicine specialist Hims & Hers is navigating a critical transformation. Despite a stock price exhibiting significant ...
Curious whether Hims & Hers Health is undervalued, overhyped, or a hidden gem? Let’s break down what recent moves and news might mean for today’s investors. The stock has delivered a wild ride lately, ...
Zacks Investment Research on MSN
HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside?
Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. HIMS and GoodRx Holdings, ...
Zacks Investment Research on MSN
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, despite its ...
In terms of liquidity and interest, the mean open interest for Hims & Hers Health options trades today is 1483.33 with a total volume of 6,561.00.
Shares of Hims & Hers are trading marginally lower Monday morning, as competitive news overshadows bullish announcements from ...
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
Hims & Hers shows platform expansion, verticalization, new Labs offerings, slower FCF growth and strong long-term revenue ...
Within the healthcare space, one company that combines fundamental safety with the high growth rates typically found in ...
Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback